Psyence Biomedical Ltd.

NASDAQ: PBM · Real-Time Price · USD
3.22
-0.13 (-3.88%)
At close: Aug 15, 2025, 3:59 PM
3.20
-0.71%
After-hours: Aug 15, 2025, 04:10 PM EDT

Psyence Biomedical Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
240.00 n/a n/a
Gross Profit
-240 n/a n/a
Operating Income
-2.75M -1.29M -334.29K
Interest Income
2.13K 1.55K n/a
Pretax Income
-51.16M 8.01M 8.23M
Net Income
-51.16M 8.01M 8.23M
Selling & General & Admin
1.8M 1.63M 1.72M
Research & Development
954.59K 1.61M 137.24K
Other Expenses
n/a n/a n/a
Operating Expenses
2.75M 1.29M 334.29K
Interest Expense
52.94K n/a n/a
Selling & Marketing Expenses
80.6K 7.03K 17.51K
Cost & Expenses
2.75M 1.29M 334.29K
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
6.52M 32.67M 32.67M
Shares Outstanding (Diluted)
6.52M 32.67M 32.67M
EPS (Basic)
-7.85 -0.64 0.25
EPS (Diluted)
-7.85 -0.64 0.25
EBITDA
-2.75M -1.29M -334.29K
EBIT
-51.11M n/a n/a
Depreciation & Amortization
240.00 n/a n/a